Quebec's drug-insurance plan 'obsolete', costly, study says

A review by a Quebec think tank of the province’s 20-year-old drug-insurance plan concludes the public/private policy is obsolete and forcing users to pay dramatically higher prices for medication available elsewhere for much less.
“The system in place favours intermediaries who profit from the system at everyone else’s expense,” Carlton University professor and review co-author Marc-André Gagnon said in a study published Friday by the Institut de recherche et d&rs